Early stage trials of the vaccine candidate, BBV154, has been completed in subjects aged 18 to 60 years, and the doses were found to be well tolerated
from Today's Paper https://ift.tt/3sh7FNm
from Today's Paper https://ift.tt/3sh7FNm
Under James Gorman, Morgan Stanley produced net income of $11 billion, compared with $9 billion a year ago. from Companies https://ift.tt/2Y9bAO0 via IFTTT
Comments
Post a Comment